Grow Therapy vs Idexx Laboratories
Side-by-side comparison of AI visibility scores, market position, and capabilities
Raised $150M Series D (Mar 2026) led by TCV and Goldman Sachs Alternatives. $1B+ annualized revenue. 7M visits in 2025. 26K providers, 220M covered lives.
About
Grow Therapy is the largest insurance-covered mental health provider marketplace in the US, connecting 26,000 therapists and psychiatrists with patients across 220 million covered lives. The company raised $150 million in Series D financing in March 2026 led by TCV and Goldman Sachs Alternatives after crossing $1 billion in annualized revenue — rare proof of genuine unit economics in behavioral health, which has historically struggled to achieve profitability at scale.
Veterinary diagnostics leader with $3.81B FY2024 revenue; 130,000+ analyzer installed base; AI-powered inVue Dx digital cytology; VetConnect data platform; pet humanization tailwind.
About
IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headquartered. The company trades on Nasdaq (IDXX) and reported $3.81 billion in revenues for FY2024, maintaining its dominant position in point-of-care veterinary diagnostics through an installed base of over 130,000 Catalyst chemistry analyzers, ProCyte hematology systems, and SNAP rapid assay devices deployed in veterinary clinics worldwide. CEO Jay Mazelsky has continued IDEXX's expansion into AI-powered diagnostics and digital pathology, building on over four decades of veterinary-specific product development.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.